0001209191-14-012050.txt : 20140219
0001209191-14-012050.hdr.sgml : 20140219
20140219200037
ACCESSION NUMBER: 0001209191-14-012050
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20140218
FILED AS OF DATE: 20140219
DATE AS OF CHANGE: 20140219
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SANGAMO BIOSCIENCES INC
CENTRAL INDEX KEY: 0001001233
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 680359556
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 501 CANAL BLVD
STREET 2: POINT RICHMOND TECH CNTR.
CITY: RICHMOND
STATE: CA
ZIP: 94804
BUSINESS PHONE: 5109706000
MAIL ADDRESS:
STREET 1: 501 CANAL BLVD
STREET 2: POINT RICHMOND TECH CNTR.
CITY: RICHMOND
STATE: CA
ZIP: 94804
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LANPHIER EDWARD O II
CENTRAL INDEX KEY: 0001234386
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-30171
FILM NUMBER: 14627514
MAIL ADDRESS:
STREET 1: C/O SANGAMO BIOSCIENCES IN STE.A-100
STREET 2: POINT RICHMOND TECH CENTER 501 CANA BLVD
CITY: RICHMOND
STATE: CA
ZIP: 94804
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2014-02-18
0
0001001233
SANGAMO BIOSCIENCES INC
SGMO
0001234386
LANPHIER EDWARD O II
C/O SANGAMO BIOSCIENCES INC.,
POINT RICHMOND TECH CNTR, 501 CANAL BLVD
RICHMOND
CA
94804
1
1
0
0
President & CEO
Common Stock
2014-02-18
4
M
0
50000
5.19
A
345000
D
Common Stock
2014-02-18
4
S
0
50000
18.087
D
295000
D
Common Stock
1595054
I
By Trust
Common Stock
100000
I
By Trust for Daughter
Employee Stock Option (Right to Buy)
5.19
2014-02-18
4
M
0
50000
0.00
D
2014-12-19
Common Stock
50000
50000
D
Includes 100,000 shares, 120,000 shares, and 75,000 shares subject to restricted stock units granted on December 8, 2011, December 6, 2012, and December 12, 2013, respectively, that will be issued as such units vest in accordance with their terms.
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 1, 2013.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.84 to $18.30, inclusive. The Reporting Person undertakes to provide to Sangamo BioSciences, Inc., any security holder of Sangamo BioSciences, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
These shares are held in the Lanphier Trust.
The Reporting Person disclaims beneficial ownership of the shares held by his child and this report shall not be deemed to be an admission that Mr. Lanphier is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
All shares underlying this option are vested and immediately exercisable, and such option will expire on December 19, 2014.
/s/ Florence Tam, attorney-in-fact
2014-02-19